PMID: 11918501Mar 29, 2002Paper

Pharmacy-based bone mass measurement to assess osteoporosis risk

The Annals of Pharmacotherapy
Mary E ElliottNeil C Binkley

Abstract

To evaluate elderly women's knowledge of their skeletal status, assess adequacy of calcium intake, determine the prevalence of low bone density, and determine whether peripheral bone density testing led to medical interventions in a group of rural, elderly Wisconsin women recruited in community pharmacies. Recruiting notices were posted in each pharmacy, and eligible women were enrolled in the order in which they volunteered. Each completed a fracture-risk questionnaire. Calcaneal bone density was measured within the following 6 weeks, using peripheral dual-energy X-ray absorptiometry. Mail surveys were used to assess interventions subsequent to the womens' study participation. The study was conducted at 5 community pharmacies in rural Wisconsin. Of 133 women, 20% had calcaneal osteoporosis, defined as a T score < or =2.5 (calcaneal bone density <2.5 SDs below the young reference database). Thirty percent of women met National Osteoporosis Foundation (NOF) treatment criteria based on heel bone density and NOF-designated risk factors. Of those meeting treatment criteria, 75% were unaware of their low bone mass. Half of the women received <1200 mg/d of calcium, the recommended dose for osteoporosis prevention. Those who were taki...Continue Reading

References

Sep 1, 1992·Journal of Gerontology·A S RyanS C Finn
Jun 15, 1992·Annals of Internal Medicine·S M Rubin, S R Cummings
Feb 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L J Melton
Feb 7, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·A C LookerS P Heyse
Mar 12, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·B L RiggsL J Melton
Jan 1, 1997·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·U UlrichC H Chesnut
Apr 10, 1999·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·B Dawson-Hughes
Sep 28, 1999·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·G Jones, F Scott
Nov 5, 1999·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·K G FaulknerP Miller
Dec 9, 2000·Journal of the American Pharmaceutical Association : APhA·W M Rosenthal
Jan 10, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J N FordhamN Kumar
Feb 15, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
Jul 11, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S L GreenspanUNKNOWN QUS-2 PMA Trials Group

❮ Previous
Next ❯

Citations

May 16, 2007·Journal of General Internal Medicine·Kathryn M RyderRonald I Shorr
Jul 2, 2011·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M N EliasS M Cadarette
Jul 5, 2005·Journal of the American Pharmacists Association : JAPhA·Timothy P StrattonKari L Meine
Jul 10, 2007·Journal of the American Pharmacists Association : JAPhA·Yifei LiuXiaoyun Pan
Apr 22, 2005·Pharmacotherapy·Eric J MacLaughlinCynthia R Raehl
May 21, 2013·The International Journal of Pharmacy Practice·Abimbola Adebukola AyorindePawana Sharma
Jun 23, 2004·Maturitas·Mary E ElliottJane E Mahoney
Feb 18, 2003·Pharmacotherapy·Sheryl L FollinMichael T McDermott
Dec 23, 2004·The Annals of Pharmacotherapy·Kelly M Summers, Tina Penick Brock
May 4, 2006·The Annals of Pharmacotherapy·Darren W GrabeMichael P Kane
Jan 27, 2004·The Annals of Pharmacotherapy·Renee M DeHart, English H Gonzalez
Jan 20, 2007·Drugs & Aging·Alexandra PapaioannouJonathan D Adachi
Oct 2, 2013·SpringerPlus·Yusra Habib KhanAmer Hayat Khan
Jun 6, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·N YukselR T Tsuyuki
Nov 24, 2005·The Annals of Pharmacotherapy·Mark NauntonGraeme Jones

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Clinical Endocrinology and Metabolism
L Y MatsuokaM F Holick
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
K G FaulknerP D Miller
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
B Dawson-Hughes
© 2022 Meta ULC. All rights reserved